By Dr Lidia Pieri (Sibyla Biotech)2024-04-19T11:45:15
Lidia Pieri earned a Master’s degree with honours in high energy physics at CERN, a PhD in theoretical astroparticle physics from Rome-3 (Italy) and an Executive MBA in Business Innovation with honours from the MIB school in Trieste. During the academic period she gained international exposure and recognition working as ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-03-28T11:38:32
Sponsored by Bio-Techne
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-02-08T11:07:39
Sponsored by Samplix ApS
2025-05-14T14:30:00
Sponsored by Abzena
Site powered by Webvision Cloud